Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)

The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Blood Pressure and Metabolic Effects of Nebivolol Compared With Hydrochlorothiazide and Placebo in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Status: Enrolling
Updated:  9/22/2010
Forest Investigative Site 033
mi
from
Columbia, SC
The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Blood Pressure and Metabolic Effects of Nebivolol Compared With Hydrochlorothiazide and Placebo in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Status: Enrolling
Updated: 9/22/2010
Forest Investigative Site 033
mi
from
Columbia, SC
Click here to add this to my saved trials
The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Blood Pressure and Metabolic Effects of Nebivolol Compared With Hydrochlorothiazide and Placebo in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Status: Enrolling
Updated:  9/22/2010
Forest Investigative site 048
mi
from
Greer, SC
The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Blood Pressure and Metabolic Effects of Nebivolol Compared With Hydrochlorothiazide and Placebo in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Status: Enrolling
Updated: 9/22/2010
Forest Investigative site 048
mi
from
Greer, SC
Click here to add this to my saved trials
The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Blood Pressure and Metabolic Effects of Nebivolol Compared With Hydrochlorothiazide and Placebo in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Status: Enrolling
Updated:  9/22/2010
Forest Investigative Site 1114
mi
from
Simpsonville, SC
The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Blood Pressure and Metabolic Effects of Nebivolol Compared With Hydrochlorothiazide and Placebo in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Status: Enrolling
Updated: 9/22/2010
Forest Investigative Site 1114
mi
from
Simpsonville, SC
Click here to add this to my saved trials
The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Blood Pressure and Metabolic Effects of Nebivolol Compared With Hydrochlorothiazide and Placebo in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Status: Enrolling
Updated:  9/22/2010
Forest Investigative Site 094
mi
from
Sioux Falls, SD
The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Blood Pressure and Metabolic Effects of Nebivolol Compared With Hydrochlorothiazide and Placebo in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Status: Enrolling
Updated: 9/22/2010
Forest Investigative Site 094
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Blood Pressure and Metabolic Effects of Nebivolol Compared With Hydrochlorothiazide and Placebo in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Status: Enrolling
Updated:  9/22/2010
Forest Investigative site 025
mi
from
Carrollton, TX
The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Blood Pressure and Metabolic Effects of Nebivolol Compared With Hydrochlorothiazide and Placebo in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Status: Enrolling
Updated: 9/22/2010
Forest Investigative site 025
mi
from
Carrollton, TX
Click here to add this to my saved trials
The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Blood Pressure and Metabolic Effects of Nebivolol Compared With Hydrochlorothiazide and Placebo in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Status: Enrolling
Updated:  9/22/2010
Forest Investigative Site
mi
from
Houston, TX
The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Blood Pressure and Metabolic Effects of Nebivolol Compared With Hydrochlorothiazide and Placebo in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Status: Enrolling
Updated: 9/22/2010
Forest Investigative Site
mi
from
Houston, TX
Click here to add this to my saved trials
The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Blood Pressure and Metabolic Effects of Nebivolol Compared With Hydrochlorothiazide and Placebo in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Status: Enrolling
Updated:  9/22/2010
Forest Investigative Site 120
mi
from
Odessa, TX
The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Blood Pressure and Metabolic Effects of Nebivolol Compared With Hydrochlorothiazide and Placebo in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Status: Enrolling
Updated: 9/22/2010
Forest Investigative Site 120
mi
from
Odessa, TX
Click here to add this to my saved trials
The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Blood Pressure and Metabolic Effects of Nebivolol Compared With Hydrochlorothiazide and Placebo in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Status: Enrolling
Updated:  9/22/2010
Forest Investigative Site 062
mi
from
San Antonio, TX
The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Blood Pressure and Metabolic Effects of Nebivolol Compared With Hydrochlorothiazide and Placebo in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Status: Enrolling
Updated: 9/22/2010
Forest Investigative Site 062
mi
from
San Antonio, TX
Click here to add this to my saved trials
The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Blood Pressure and Metabolic Effects of Nebivolol Compared With Hydrochlorothiazide and Placebo in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Status: Enrolling
Updated:  9/22/2010
Forest Investigative Site 1316
mi
from
Sugar Land, TX
The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Blood Pressure and Metabolic Effects of Nebivolol Compared With Hydrochlorothiazide and Placebo in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Status: Enrolling
Updated: 9/22/2010
Forest Investigative Site 1316
mi
from
Sugar Land, TX
Click here to add this to my saved trials
The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Blood Pressure and Metabolic Effects of Nebivolol Compared With Hydrochlorothiazide and Placebo in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Status: Enrolling
Updated:  9/22/2010
Forest Investigative Site 040
mi
from
Bountiful, UT
The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Blood Pressure and Metabolic Effects of Nebivolol Compared With Hydrochlorothiazide and Placebo in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Status: Enrolling
Updated: 9/22/2010
Forest Investigative Site 040
mi
from
Bountiful, UT
Click here to add this to my saved trials
The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Blood Pressure and Metabolic Effects of Nebivolol Compared With Hydrochlorothiazide and Placebo in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Status: Enrolling
Updated:  9/22/2010
Forest Investigative site 100
mi
from
Salt Lake City, UT
The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Blood Pressure and Metabolic Effects of Nebivolol Compared With Hydrochlorothiazide and Placebo in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Status: Enrolling
Updated: 9/22/2010
Forest Investigative site 100
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Blood Pressure and Metabolic Effects of Nebivolol Compared With Hydrochlorothiazide and Placebo in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Status: Enrolling
Updated:  9/22/2010
Forest Investigative Site 076
mi
from
West Jordan, UT
The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Blood Pressure and Metabolic Effects of Nebivolol Compared With Hydrochlorothiazide and Placebo in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Status: Enrolling
Updated: 9/22/2010
Forest Investigative Site 076
mi
from
West Jordan, UT
Click here to add this to my saved trials
The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Blood Pressure and Metabolic Effects of Nebivolol Compared With Hydrochlorothiazide and Placebo in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Status: Enrolling
Updated:  9/22/2010
Forest Investigative Site 1786
mi
from
Arlington, VA
The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Blood Pressure and Metabolic Effects of Nebivolol Compared With Hydrochlorothiazide and Placebo in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Status: Enrolling
Updated: 9/22/2010
Forest Investigative Site 1786
mi
from
Arlington, VA
Click here to add this to my saved trials
Trial Using Motivational Interviewing Positive Affect and Self-Affirmation in Hypertension (TRIUMPH)
Trial Using Motivational Interviewing Positive Affect and Self-Affirmation in Hypertension (TRIUMPH)
Status: Enrolling
Updated:  11/4/2010
Lincoln Medical & Mental Health Center
mi
from
Bronx, NY
Trial Using Motivational Interviewing Positive Affect and Self-Affirmation in Hypertension (TRIUMPH)
Trial Using Motivational Interviewing Positive Affect and Self-Affirmation in Hypertension (TRIUMPH)
Status: Enrolling
Updated: 11/4/2010
Lincoln Medical & Mental Health Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Effects of the Beta-blocker Nebivolol (Bystolic) on Subjects With High Normal Blood Pressure and/or a Family History of Hypertension
Effects of the Novel Beta-adrenergic Antagonist Nebivolol (Bystolic) on Prehypertensive Subjects at Genetic Risk of Hypertension: Implications for Inflammation, Endothelial Dysfunction, and Oxidative Stress.
Status: Enrolling
Updated:  12/10/2010
The University of California, San Diego
mi
from
La Jolla, CA
Effects of the Beta-blocker Nebivolol (Bystolic) on Subjects With High Normal Blood Pressure and/or a Family History of Hypertension
Effects of the Novel Beta-adrenergic Antagonist Nebivolol (Bystolic) on Prehypertensive Subjects at Genetic Risk of Hypertension: Implications for Inflammation, Endothelial Dysfunction, and Oxidative Stress.
Status: Enrolling
Updated: 12/10/2010
The University of California, San Diego
mi
from
La Jolla, CA
Click here to add this to my saved trials
24-hour Effect of Bimatoprost
24-hour IOP-lowering Effect of 0.01% Bimatoprost
Status: Enrolling
Updated:  1/6/2011
UCSD Shiley Eye Center
mi
from
La Jolla, CA
24-hour Effect of Bimatoprost
24-hour IOP-lowering Effect of 0.01% Bimatoprost
Status: Enrolling
Updated: 1/6/2011
UCSD Shiley Eye Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
Exercise Training in Type 2 Diabetes and Hypertension
Exercise Training in Type 2 Diabetes and Hypertension
Status: Enrolling
Updated:  2/3/2011
Johns Hopkins Bayview Medical Center
mi
from
Baltimore, MD
Exercise Training in Type 2 Diabetes and Hypertension
Exercise Training in Type 2 Diabetes and Hypertension
Status: Enrolling
Updated: 2/3/2011
Johns Hopkins Bayview Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Coreg CR, Blood Vessel Stiffness and Blood Vessel Function
Effect of Coreg CR on BP, Endothelial Function, Exhaled Nitric Oxide, and Nitric Oxide Production and Oxidation
Status: Enrolling
Updated:  2/9/2011
SUNY Downstate Medical Center
mi
from
Brooklyn, NY
Coreg CR, Blood Vessel Stiffness and Blood Vessel Function
Effect of Coreg CR on BP, Endothelial Function, Exhaled Nitric Oxide, and Nitric Oxide Production and Oxidation
Status: Enrolling
Updated: 2/9/2011
SUNY Downstate Medical Center
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Safety and Efficacy of Fluoxetine in Pulmonary Arterial Hypertension
Safety and Efficacy of Fluoxetine in Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  3/15/2011
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Safety and Efficacy of Fluoxetine in Pulmonary Arterial Hypertension
Safety and Efficacy of Fluoxetine in Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 3/15/2011
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Modifying Dietary Behavior in Adolescents With Elevated Blood Pressure
Modifying Dietary Behavior in Adolescents With Elevated Blood Pressure
Status: Enrolling
Updated:  3/23/2011
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Modifying Dietary Behavior in Adolescents With Elevated Blood Pressure
Modifying Dietary Behavior in Adolescents With Elevated Blood Pressure
Status: Enrolling
Updated: 3/23/2011
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Oral L-Citrulline and ADMA in Pregnancy
Phase 1 Study of Oral L-citrulline on ADMA/L-arginine and Endothelial-dependent Vascular Function in Pregnancy.
Status: Enrolling
Updated:  6/15/2011
Magee-Womens Hospital of UPMC
mi
from
Pittsburgh, PA
Oral L-Citrulline and ADMA in Pregnancy
Phase 1 Study of Oral L-citrulline on ADMA/L-arginine and Endothelial-dependent Vascular Function in Pregnancy.
Status: Enrolling
Updated: 6/15/2011
Magee-Womens Hospital of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Stroke Health and Risk Education (SHARE)
Stroke Health and Risk Education (SHARE)
Status: Enrolling
Updated:  6/22/2011
Corpus Christi Catholic Churches
mi
from
Corpus Christi, TX
Stroke Health and Risk Education (SHARE)
Stroke Health and Risk Education (SHARE)
Status: Enrolling
Updated: 6/22/2011
Corpus Christi Catholic Churches
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
Enhanced Spanish Drug Label Study to Promote Patient Understanding and Use
Enhanced Spanish Drug Label Design to Promote Patient Understanding and Use
Status: Enrolling
Updated:  7/19/2011
Northwestern University
mi
from
Chicago, IL
Enhanced Spanish Drug Label Study to Promote Patient Understanding and Use
Enhanced Spanish Drug Label Design to Promote Patient Understanding and Use
Status: Enrolling
Updated: 7/19/2011
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Aerobic Training and Arterial Stiffness in Chronic Kidney Disease (CKD) Patients
The Effect of Short-term Aerobic Training on Arterial Stiffness and Blood in Chronic Kidney Disease (CKD) Patients
Status: Enrolling
Updated:  7/20/2011
Athletic Training and Exercise Science Building
mi
from
Springfield, MA
Aerobic Training and Arterial Stiffness in Chronic Kidney Disease (CKD) Patients
The Effect of Short-term Aerobic Training on Arterial Stiffness and Blood in Chronic Kidney Disease (CKD) Patients
Status: Enrolling
Updated: 7/20/2011
Athletic Training and Exercise Science Building
mi
from
Springfield, MA
Click here to add this to my saved trials
The Effect of a Peroxisome Proliferator-activated Receptor (PPAR) Alpha Agonist on Cytochrome P450 (CYP) Monooxygenase Activity in Humans
The Effect of a PPAR Alpha Agonist on CYP Monooxygenase Activity in Humans
Status: Enrolling
Updated:  7/25/2011
Vanderbilt University
mi
from
Nashville, TN
The Effect of a Peroxisome Proliferator-activated Receptor (PPAR) Alpha Agonist on Cytochrome P450 (CYP) Monooxygenase Activity in Humans
The Effect of a PPAR Alpha Agonist on CYP Monooxygenase Activity in Humans
Status: Enrolling
Updated: 7/25/2011
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Monetary Incentives and Intrinsic Motivation to Sustain Hypertension Control
Monetary Incentives and Intrinsic Motivation to Sustain Hypertension Control Pilot Study
Status: Enrolling
Updated:  7/25/2011
St. John's Well Child and Family Center Compton W.M. Keck Foundation Clinic Building
mi
from
Los Angeles, CA
Monetary Incentives and Intrinsic Motivation to Sustain Hypertension Control
Monetary Incentives and Intrinsic Motivation to Sustain Hypertension Control Pilot Study
Status: Enrolling
Updated: 7/25/2011
St. John's Well Child and Family Center Compton W.M. Keck Foundation Clinic Building
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Monetary Incentives and Intrinsic Motivation to Sustain Hypertension Control
Monetary Incentives and Intrinsic Motivation to Sustain Hypertension Control Pilot Study
Status: Enrolling
Updated:  7/25/2011
St. John's Well Child and Family Center Dr. Louis C. Frayser Clinic
mi
from
Los Angeles, CA
Monetary Incentives and Intrinsic Motivation to Sustain Hypertension Control
Monetary Incentives and Intrinsic Motivation to Sustain Hypertension Control Pilot Study
Status: Enrolling
Updated: 7/25/2011
St. John's Well Child and Family Center Dr. Louis C. Frayser Clinic
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Inhaled Iloprost as an Adjunct to Inhaled Nitric Oxide in Pediatric Critical Care Patients
A Randomized, Double Blind, Placebo-controlled Pilot Study of the Safety and Effective Dosing of Inhaled Iloprost in Pediatric Patients With Pulmonary Hypertension Treated With Inhaled Nitric Oxide
Status: Enrolling
Updated:  7/29/2011
Seattle Children's Hospital
mi
from
Seattle, WA
Inhaled Iloprost as an Adjunct to Inhaled Nitric Oxide in Pediatric Critical Care Patients
A Randomized, Double Blind, Placebo-controlled Pilot Study of the Safety and Effective Dosing of Inhaled Iloprost in Pediatric Patients With Pulmonary Hypertension Treated With Inhaled Nitric Oxide
Status: Enrolling
Updated: 7/29/2011
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
Safety, Tolerability, and PK Parameters of Sodium Nitrite Inhalation Solution in Healthy Subjects
A Phase 1, Placebo Controlled, Blinded, Multiple Dose Escalation Study of AIR001 (Sodium Nitrite Inhalation Solution) in Healthy Subjects and an Assessment of the Tolerability in Combination With Oral Sildenafil
Status: Enrolling
Updated:  8/3/2011
PAREXEL International Early Phase Clinical Unit - Baltimore
mi
from
Baltimore, MD
Safety, Tolerability, and PK Parameters of Sodium Nitrite Inhalation Solution in Healthy Subjects
A Phase 1, Placebo Controlled, Blinded, Multiple Dose Escalation Study of AIR001 (Sodium Nitrite Inhalation Solution) in Healthy Subjects and an Assessment of the Tolerability in Combination With Oral Sildenafil
Status: Enrolling
Updated: 8/3/2011
PAREXEL International Early Phase Clinical Unit - Baltimore
mi
from
Baltimore, MD
Click here to add this to my saved trials
Lifestyle Modification and Blood Pressure Study
Lifestyle Modification and Blood Pressure Study
Status: Enrolling
Updated:  8/4/2011
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Lifestyle Modification and Blood Pressure Study
Lifestyle Modification and Blood Pressure Study
Status: Enrolling
Updated: 8/4/2011
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Dose-Escalation Study Designed to Evaluate the Tolerability, Safety, Pharmacokinetics (PK), and Efficacy of Chronic Topical Ocular Application of INO-8875 in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma
A Phase I/II Multi-Center, Randomized, Double-Masked, Placebo-Controlled, Dose-Escalation Study to Evaluate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics (Efficacy) of Chronic Twice-Daily Topical Monocular Application of INO-8875 Ophthalmic Formulation in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma
Status: Enrolling
Updated:  8/30/2011
Lugene Eye Institute
mi
from
Glendale, CA
A Dose-Escalation Study Designed to Evaluate the Tolerability, Safety, Pharmacokinetics (PK), and Efficacy of Chronic Topical Ocular Application of INO-8875 in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma
A Phase I/II Multi-Center, Randomized, Double-Masked, Placebo-Controlled, Dose-Escalation Study to Evaluate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics (Efficacy) of Chronic Twice-Daily Topical Monocular Application of INO-8875 Ophthalmic Formulation in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma
Status: Enrolling
Updated: 8/30/2011
Lugene Eye Institute
mi
from
Glendale, CA
Click here to add this to my saved trials
Acute Carotid Sinus Endovascular Stimulation II Study
Acute Carotid Sinus Endovascular Stimulation II Study
Status: Enrolling
Updated:  10/20/2011
Clinical Research Facility
mi
from
Ann Arbor, MI
Acute Carotid Sinus Endovascular Stimulation II Study
Acute Carotid Sinus Endovascular Stimulation II Study
Status: Enrolling
Updated: 10/20/2011
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  11/1/2011
Sall Research Medical Center, Inc.
mi
from
Artesia, CA
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/1/2011
Sall Research Medical Center, Inc.
mi
from
Artesia, CA
Click here to add this to my saved trials
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  11/1/2011
USC Department of Ophthalmology
mi
from
Los Angeles, CA
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/1/2011
USC Department of Ophthalmology
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  11/1/2011
Wolstan Eye Associates
mi
from
Torrance, CA
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/1/2011
Wolstan Eye Associates
mi
from
Torrance, CA
Click here to add this to my saved trials
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  11/1/2011
East Florida Eye Institute
mi
from
Stuart, FL
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/1/2011
East Florida Eye Institute
mi
from
Stuart, FL
Click here to add this to my saved trials
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  11/1/2011
Seidenberg Protzko Eye Associates
mi
from
Bel Air, MD
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/1/2011
Seidenberg Protzko Eye Associates
mi
from
Bel Air, MD
Click here to add this to my saved trials
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  11/1/2011
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/1/2011
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  11/1/2011
Rochester Ophthalmological Group
mi
from
Rochester, NY
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/1/2011
Rochester Ophthalmological Group
mi
from
Rochester, NY
Click here to add this to my saved trials
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  11/1/2011
Cornerstone Eye Care
mi
from
High Point, NC
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/1/2011
Cornerstone Eye Care
mi
from
High Point, NC
Click here to add this to my saved trials
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  11/1/2011
Associated Glaucoma Consultants
mi
from
Philadelphia, PA
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/1/2011
Associated Glaucoma Consultants
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  11/1/2011
Keystone Research Ltd.
mi
from
Austin, TX
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/1/2011
Keystone Research Ltd.
mi
from
Austin, TX
Click here to add this to my saved trials
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  11/1/2011
David Shulman, MD P-A
mi
from
San Antonio, TX
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/1/2011
David Shulman, MD P-A
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  11/1/2011
Eye Clinics of South Texas
mi
from
San Antonio, TX
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/1/2011
Eye Clinics of South Texas
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  11/1/2011
Medical Center Ophthalmology Associates
mi
from
San Antonio, TX
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/1/2011
Medical Center Ophthalmology Associates
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  11/1/2011
Virginia Eye Consultants
mi
from
Norfolk, VA
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/1/2011
Virginia Eye Consultants
mi
from
Norfolk, VA
Click here to add this to my saved trials
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active-controlled, Multi-Center, Dose Escalation Trial of DE-104 Ophthalmic Solution in Japanese and Non-Japanese Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  11/1/2011
Clinical Research Facility
mi
from
Artesia, CA
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active-controlled, Multi-Center, Dose Escalation Trial of DE-104 Ophthalmic Solution in Japanese and Non-Japanese Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/1/2011
Clinical Research Facility
mi
from
Artesia, CA
Click here to add this to my saved trials
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active-controlled, Multi-Center, Dose Escalation Trial of DE-104 Ophthalmic Solution in Japanese and Non-Japanese Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  11/1/2011
Clinical Research Facility
mi
from
Pasadena, CA
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active-controlled, Multi-Center, Dose Escalation Trial of DE-104 Ophthalmic Solution in Japanese and Non-Japanese Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/1/2011
Clinical Research Facility
mi
from
Pasadena, CA
Click here to add this to my saved trials
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active-controlled, Multi-Center, Dose Escalation Trial of DE-104 Ophthalmic Solution in Japanese and Non-Japanese Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  11/1/2011
Clinical Research Facility
mi
from
San Francisco, CA
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active-controlled, Multi-Center, Dose Escalation Trial of DE-104 Ophthalmic Solution in Japanese and Non-Japanese Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/1/2011
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active-controlled, Multi-Center, Dose Escalation Trial of DE-104 Ophthalmic Solution in Japanese and Non-Japanese Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  11/1/2011
Clinical Research Facility
mi
from
Honolulu, HI
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
A Randomized, Double-masked, Placebo- and Active-controlled, Multi-Center, Dose Escalation Trial of DE-104 Ophthalmic Solution in Japanese and Non-Japanese Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 11/1/2011
Clinical Research Facility
mi
from
Honolulu, HI
Click here to add this to my saved trials